Literature DB >> 19102133

Is there a need for positron emission tomography imaging to stage the N0 neck in T1-T2 squamous cell carcinoma of the oral cavity or oropharynx?

Ursula Schroeder1, Markus Dietlein, Claus Wittekindt, Monika Ortmann, Hartmut Stuetzer, Julia Vent, Markus Jungehuelsing, Barbara Krug.   

Abstract

OBJECTIVES: We assess whether negative findings on computed tomography (CT), magnetic resonance imaging (MRI), and/or 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) may contribute to the decision-making process of elective neck dissection (eND) in patients with squamous cell carcinoma of the oral cavity or the oropharynx (oSCC) staged cT1-T2 cN0 cM0.
METHODS: We interpreted CT, MRI, and 18FDG-PET images separately, after combining the data of CT with those of 18FDG-PET and the data of MRI with those of 18FDG-PET. Each set of results was then compared with the histopathologic results of ipsilateral or bilateral eND in a prospective, blinded study.
RESULTS: The histopathologic examination of 594 lymph nodes revealed 4 metastases less than 4 mm in diameter and 3 micrometastases (less than 2 mm) in 6 of 17 patients. On CT, MRI, and 18FDG-PET, respectively, 5, 5, and 0 cases were true-malignant (true positives) and 4, 10, and 1 cases were false-malignant (false positives). The accuracy was not enhanced by fusing CT with 18FDG-PET or MRI with 18FDG-PET.
CONCLUSIONS: The detectability threshold of occult metastases appears to be below the spatial and contrast resolution of CT, MRI, and 18FDG-PET. The decision for eND in patients with cT1-T2 cN0 cM0 oSCC cannot be based upon cross-sectional imaging at the resolutions currently available.

Entities:  

Mesh:

Year:  2008        PMID: 19102133     DOI: 10.1177/000348940811701111

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  12 in total

1.  Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.

Authors:  Val J Lowe; Fenghai Duan; Rathan M Subramaniam; JoRean D Sicks; Justin Romanoff; Twyla Bartel; Jian Q Michael Yu; Brian Nussenbaum; Jeremy Richmon; Charles D Arnold; David Cognetti; Brendan C Stack
Journal:  J Clin Oncol       Date:  2019-02-15       Impact factor: 44.544

2.  Management of neck metastases of unknown primary origin united in two European centers.

Authors:  Jos Straetmans; Julia Vent; Martin Lacko; Ernst-Jan Speel; Christian Huebbers; Robert Semrau; Frank Hoebers; Zlatan Mujagic; Jens-Peter Klussmann; Simon F Preuss; Bernd Kremer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-11       Impact factor: 2.503

3.  Role of positron emission tomography in the treatment of occult disease in head-and-neck cancer: a modeling approach.

Authors:  Mark H Phillips; Wade P Smith; Upendra Parvathaneni; George E Laramore
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-25       Impact factor: 7.038

4.  Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.

Authors:  Benedikt Michael Schaarschmidt; Philipp Heusch; Christian Buchbender; Marcus Ruhlmann; Christoph Bergmann; Verena Ruhlmann; Marc Schlamann; Gerald Antoch; Michael Forsting; Axel Wetter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-06       Impact factor: 9.236

5.  Evaluation of cervical lymph nodes with CT perfusion in patients with hypopharyngeal and laryngeal squamous cell cancer.

Authors:  Piotr Trojanowski; Janusz Klatka; Agnieszka Trojanowska; Tomasz Jargiełło; Andrzej Drop
Journal:  Pol J Radiol       Date:  2011-01

6.  Staging of cervical lymph nodes in oral squamous cell carcinoma: adding ultrasound in clinically lymph node negative patients may improve diagnostic work-up.

Authors:  Rikke Norling; Birgitte Marie Due Buron; Marianne Hamilton Therkildsen; Birthe Merete Henriksen; Christian von Buchwald; Michael Bachmann Nielsen
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

7.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

8.  Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.

Authors:  Maliha Sadick; Stefan O Schoenberg; Karl Hoermann; Haneen Sadick
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

9.  Focus issue: neck dissection for oropharyngeal squamous cell carcinoma.

Authors:  Kathryn M Van Abel; Eric J Moore
Journal:  ISRN Surg       Date:  2012-01-15

10.  Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous 18F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer?

Authors:  N Pyatigorskaya; R De Laroche; G Bera; A Giron; C Bertolus; G Herve; E Chambenois; S Bergeret; D Dormont; M Amor-Sahli; A Kas
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-24       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.